Lazard Asset Management LLC Abeona Therapeutics Inc. Transaction History
Lazard Asset Management LLC
- $68.3 Billion
- Q3 2024
A detailed history of Lazard Asset Management LLC transactions in Abeona Therapeutics Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 116 shares of ABEO stock, worth $667. This represents 0.0% of its overall portfolio holdings.
Number of Shares
116
Previous 163
28.83%
Holding current value
$667
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ABEO
# of Institutions
61Shares Held
26.8MCall Options Held
614KPut Options Held
45K-
Suvretta Capital Management, LLC New York, NY3.69MShares$21.2 Million0.92% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.43MShares$19.7 Million1.29% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.25MShares$18.7 Million0.04% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.3MShares$13.2 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.01MShares$11.5 Million0.0% of portfolio
About ABEONA THERAPEUTICS INC.
- Ticker ABEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,950,380
- Market Cap $34.2M
- Description
- Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...